Reported research findings
- Human clinical evidence is limited to date; the strongest data comes from preclinical models.
LONGEVITY & METABOLIC RESEARCH
MOTS-C
A peptide encoded by the mitochondria themselves, studied as a metabolic regulator and exercise mimetic.
MOTS-c is a short peptide encoded not by the cell's main DNA but by the mitochondria—the structures that produce cellular energy. It is studied as a metabolic regulator and “exercise mimetic,” with a well-defined mechanism: it activates AMPK, the cell's low-energy sensor. Evidence to date is primarily preclinical.
Why BLP features MOTS-C
Included because it has a specific, well-defined mitochondrial mechanism (AMPK activation) and compelling preclinical metabolic data. Human clinical evidence remains limited, so it is presented as experimental despite growing research interest.
Mechanism
Moves into the cell nucleus, where it changes which genes are switched on.
Activates AMPK, the sensor cells use to detect low energy—increasing fat burning and insulin sensitivity.
Prompts the cell to build more mitochondria and take up more glucose, mimicking the cellular effects of exercise.
WHAT THE RESEARCH MEASURED
Research findings
Findings describe study outcomes, not expected personal results.
Preclinical findings
- In models: reported fat loss (especially lower abdomen), improved insulin sensitivity, and better blood-sugar control.
- Reported increased endurance and training capacity.
- Reported anti-aging effects on metabolism and muscle.
- Extremely well tolerated in research use.
Regulatory status
MOTS-C is investigational with primarily preclinical evidence. Sold and offered strictly for laboratory and research use.